Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 295

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 295
---
 as described below.                                          |

The 2020 Notes bear no interest
and, unless previously converted (see below), shall become fully due and payable in cash following one (1) year from each 2020 CLA issuance
date. The 2020 Notes may be converted into the most senior securities of the Company or repaid as follows:

| 1. | Automatic conversion                                                                                                                   
 upon occurrence of a qualified round – upon the closing of a qualified round (transaction or series of related transactions            
 in which shares of the Company having substantially similar rights are issued for an aggregate investment amount of at least $ 3,000), 
 the 2020 Notes shall be automatically be converted into such number of shares of the most senior securities issued in such qualified   
 round, based on a price per share equal to 80% of the lowest price per share actually paid by any investor in the qualified round.     |

| 2. | Automatic conversion                                                                                                         
 upon occurrence of a merger and acquisition transaction – upon the closing of merger and acquisition transaction (as defined 
 in the 2020 CLAs), the 2020 Notes shall be automatically converted into Company’s most senior securities, based on a price   
 per share equal to 80% of the lowest price per attributed to such securities in the merger and acquisition transaction.      |

In October 2021, the Company and 2020
CLA investors reached an agreement according to which, in connection with the raising of the 2021 Notes, the 2020 Notes will be converted
into Ordinary Shares upon the occurrence of an exit event (including an IPO or merger) of the Company based on a price per share equal
to 80% at a pre money valuation of $5,150.

On January 3, 2024, the Company extended
the due date of the 2020 Notes until April 30, 2024 and, subsequently, on April 26, 2024, further extended the due date until May 27,
2024, and in March 2025 further extended to August 31, 2025. Regarding additional term extension, see also Note 9.

| b. | In October 2024, the Company                                                                           
 entered into an addendum to the 2020 CLAs (the “October 2024 CLA Addendum”) pursuant                   
 to which the Company will issue additional notes up to an additional aggregate amount of $450 to       
 certain lenders (the “Participating Lenders”). Purs